SCHEMBL21828501

SCHEMBL21828501

CC1N(C(=O)O)CCC1(C)O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1643952 1.00 FFAR3 (0.32) FFAR3
SCHEMBL5487990 0.83 FFAR3 (0.32) FFAR3
SCHEMBL22286828 0.80 FFAR3 (0.33) FFAR3
SCHEMBL16211666 0.77
SCHEMBL3281473 0.76
SCHEMBL3275477 0.76
SCHEMBL21408171 0.75 DPP4 (0.35) FFAR3
SCHEMBL3275448 0.75
SCHEMBL3279795 0.75
SCHEMBL25286794 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3861000-A1 THIENO[3,2-B]PYRIDINE DERIVATIVES AS UDP GLYCOSYLTRANSFERASE INHIBITORS AND METHODS OF USE Genzyme Corporation (US) 2021-08-11 EP disclosed
WO-2020072504-A1 THIENO[3,2-B]PYRIDINE DERIVATIVES AS UDP GLYCOSYLTRANSFERASE INHIBITORS AND METHODS OF USE GENZYME CORPORATION (US) 2020-04-09 WO disclosed